46
Assay for limit dextrinase and pullulanase / M. Bøjstrup et al. / Anal. Biochem. 449 (2014) 45–51
Scheme 1. Synthesis of the chromogenic substrate 1. (a) Ac2O, pyridine, DMAP, RT, 100%; (b) 33% HBr in AcOH, Ac2O, DCM, 0 °C, 2 h, 100%. (c) 2-Chloro-4-nitrophenol, TBABr,
aqueous NaOH (0.75 M), DCM, RT, 20%. (d) MeOH/Et3N/H2O (2:2:1), RT, 24 h, 37%.
glycosylation of 2-chloro-4-nitrophenol (ClNP) was performed in
the presence of tetrabutylammonium bromide (TBABr) as phase-
transfer catalyst using 3 equivalents of ClNP in a two-phase system
(0.75 M aqueous sodium hydroxide/dichloromethane) [10]. Finally,
O-deacetylation of the peracetylated glycoside 5 provided us with
the target compound 1 in an unoptimized overall yield of 7.4%. The
experimental details are described below.
All commercially available solvents and reagents were used
without further purification. Organic solvents were removed under
diminished pressure at less than 40 °C (bath temperature). Thin
layer chromatography (TLC) was carried out on silica plates (Merck
60 F254 aluminum plates) with detection by ultraviolet (UV) light
(short wavelength) or 10% sulfuric acid in ethanol. Column chro-
matography was performed on silica gel (Merck, 230–400, 60 Å).
Matrix-assisted laser desorption/ionization time-of-flight mass
and the organic phase was washed with saturated NaHCO3 and
brine, dried (Na2SO4), filtered, and concentrated. The residue was
purified by flash chromatography (EtOAc/hexane, 2:1 and then
4:1). Fractions containing the desired compound were concen-
trated to give 5 as a colorless oil (11 mg, 20%).
The peracetylated glycoside 5 from above was dissolved in
MeOH/Et3N/H2O (2:2:1, 5 ml). The mixture was left stirring over-
night. The mixture was evaporated and passed through mixed
bed resin (MB-1) to remove salts. The fractions containing com-
pound were concentrated to give compound 1 as a white powder
(2.4 mg, 37%). The overall yield was 7.4%.
1H NMR (800 MHz, D2O): d 8.41 (d, 1H, J = 2.7 Hz), 8.21 (dd, 1H,
J = 2.7, 9.2 Hz), 7.38 (d, 1H, J = 9.2 Hz), 5.44 (d, 1H, J = 3.8 Hz), 5.35–
5.37 (m, 3H), 5.34 (d, 1H, J = 7.8 Hz), 4.93 (m, 2H), 3.44–4.01 (m,
41H), 3.41 (dd, 1H, J = 9.7, 9.7 Hz); 13C NMR (201 MHz, D2O): d
157.0, 142.2, 125.9, 124.0, 123.0, 115.3, 99.8, 99.7, 99.4, 99.4,
99.2, 97.8, 97.6, 77.3, 77.0, 76.9, 76.0, 75.5, 74.7, 73.1, 73.0, 73.0,
72.8, 72.8, 72.7, 72.1, 71.5, 71.4, 71.4, 71.3, 71.2, 71.2, 71.2, 71.1,
71.0, 70.9, 70.9, 70.0, 69.2, 69.2, 69.1, 66.1, 65.6, 60.4, 60.2, 60.2,
60.1, 60.1.
spectrometry (MALDI–ToF–MS) was performed on
a Bruker
Daltonics Microflex instrument operating in reflectron mode. A
340-nm laser was used, and mass spectra were typically accumu-
lated from 100 laser shots. Nuclear magnetic resonance (NMR)
spectra were recorded on a Bruker Daltonics Avance 800-MHz
spectrometer equipped with a 5-mm TCI cryoprobe operating at
298 K. D2O was obtained from Cambridge Isotope Laboratory.
Spectra are internally referenced to the solvent residual proton.
Spectra were processed using Bruker Topspin 2.0. Glc-maltotrio-
syl-maltotriose was purchased from Megazyme. All other chemi-
cals were purchased from Sigma–Aldrich.
Standard malt extraction
Malt flour (0.5 g) was shaken with 4 ml of extraction buffer
(100 mM NaOAc and 5 mM CaCl2, pH 5.3) for 30 min. The slurry
was centrifuged for 10 min, and the supernatant was used
immediately.
Glc-maltotriosyl-maltotriose 2 (30.0 mg, 25 lmol) was sus-
pended in dry pyridine (3 ml). Acetic anhydride (2 ml) and a cata-
lytic amount of DMAP were added, and the mixture was left at
room temperature (RT) overnight. Additional acetic anhydride
(0.5 ml) was added, and the mixture was stirred at RT overnight.
Recombinantly derived barley LD
The barley LD gene (HvLD) was expressed in Escherichia coli or
codon optimized for Pichia pastoris expression by GenScript for
MALDI–ToF–MS (with
a-cyano-4-hydroxycinnamic acid [4-HCCA]
as matrix) showed completion of the reaction. The solvents were
evaporated in vacuo. The residue was dissolved in DCM, washed
with aqueous HCl (0.2 M), saturated NaHCO3, and brine, dried (Na2-
SO4), filtered, concentrated in vacuo, and coevaporated twice with
toluene. This gave the peracetylated product in quantitative yield.
cloning into the pPinka-HC vector. The pPinka-HC-HvLD vector
was linearized with Afl II and transformed into PichiaPink strain
1 from Invitrogen. Screening for colonies was done as described
in the Invitrogen user manual [11]. The expression level in Pichia-
Pink was at the same level as described by others [12].
The peracetylated sugar (53 mg, 25 lmol) was dissolved in
DCM (3 ml). Acetic anhydride (0.15 ml) was added, and the mix-
ture was cooled to 0 °C. Two drops of HBr (33% in AcOH) were
added, and the mixture was stirred at 0 °C for 10 min. HBr (33%
in AcOH, 3 ml) was added, and the mixture was stirred at 0 °C for
2 h. The mixture was concentrated in vacuo, coevaporated with
toluene, and used in the next step without further purification.
Enzymatic assay
The assay development and optimization was done in 50-ll
total volume in each well (Nunc 96-well plate, half area). Two
replicates were made. As background was used the concentration
of substrate with no debranching enzyme added. This blank was
subtracted from the measured values. All experiments were per-
formed using a 100-mM HOAc/NaOAc buffer containing 5 mM
The residual bromosugar 4 (53 mg, 25
DCM (2 ml) and aqueous NaOH (0.75 M, 1 ml). ClNP (14 mg,
80 mol) and TBABr (8 mg, 24.8 mol) were added, and the mix-
ture was stirred vigorously at RT overnight. DCM (5 ml) was added,
lmol) was dissolved in
l
l
CaCl2 (pH 5.3) at 45 °C.
750 U/ml), b-glucosidase (Agrobacterium sp., 380 U/ml), and
a-Glucosidase (Bacillus stereaothermophilus,